跳至主要内容
临床试验/ISRCTN15320623
ISRCTN15320623进行中(未招募)Unknown

Bronchiectasis Research Into Leukocyte biology and Lung Infections to Accelerate New Therapies (BRILLIANT)

niversity of Dundee0 个研究点目标入组 80 人开始时间: 2023年4月27日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Bronchiectasis cohort:
  • 1. Age >18 years
  • 2. Bronchiectasis diagnosed by CT scan
  • 3. Symptoms consistent with bronchiectasis: cough, sputum and/or frequent respiratory tract infections
  • 4. Clinically stable defined by the absence of antibiotic therapy in the previous 4 weeks
  • Healthy control cohort:
  • 1. Age >18 years

排除标准

  • Bronchiectasis cohort:
  • 1. A primary diagnosis of asthma or COPD (secondary diagnoses and individuals with historical misdiagnosis will be permitted)
  • 2. Immunodeficiency requiring immunoglobulin replacement therapy
  • 3. Active allergic bronchopulmonary aspergillosis (defined by receipt of oral corticosteroids or anti-fungal therapy)
  • 4. Active tuberculosis
  • 5. Traction bronchiectasis due to interstitial lung disease
  • 6. Active SARS-CoV-2 infection or contact with a confirmed case in the previous 14 days
  • 7. Active malignancy excluding non-melanoma skin cancer
  • 8. Antibiotic treatment for an acute respiratory tract infection or exacerbation in the previous 4 weeks
  • 9. Treatment with anticoagulants
  • 10. Any contraindication to study procedures including bronchoscopy
  • 11. Current smoking or smoking in the preceding 3 months
  • Healthy control cohort:
  • 1. Any respiratory diagnosis (asthma, COPD, bronchiectasis, pulmonary fibrosis or any other chronic respiratory condition requiring regular treatment)
  • 2. Inflammatory conditions including rheumatoid arthritis, inflammatory bowel disease, and any other connective tissue disease
  • 3. Active SARS-CoV-2 infection or contact with a confirmed case in the previous 14 days
  • 4. Active malignancy excluding non-melanoma skin cancer
  • 5. Antibiotic treatment for an acute respiratory tract infection in the previous 4 weeks
  • 6. Any contraindication to study procedures including bronchoscopy
  • 7. Current smoking or smoking in the preceding 3 months
  • 8. Upper respiratory tract infection in the previous 4 weeks or current sinusitis
  • 9. Treatment with anticoagulants

研究者

发起方
niversity of Dundee

相似试验